Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Gold Standard:clinical outcome
nucleic acid test
Index test:antigen reagent
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
10 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1)Complete sample information, including sample number, gender, age, sampling time, and clinical diagnosis background information (2)New coronavirus-infected pneumonia confirmed cases (including partial recovery cases), excluded cases, etc. (Confirmed cases should include patients with different disease processes (such as early, middle, late treatment / recovery patients, etc.) (3)Consecutive samples collected at different times from some patients with pneumonitis infected by the new coronavirus were included, including samples from each stage of the new coronavirus nucleic acid and antigen / antibody from negative to positive (4)The samples were selected as inpatients and outpatient patients for clinical needs.The remaining samples can be tested by clinical units or stored as frozen samples.
Exclusion criteria
Exclusion criteria: (1)Unclear sample collection time or information (2)Insufficient sample size due to mistakes in the test operation (3)Contaminated sample.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| new coronavirus nucleocapsid (N) antigen;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactZhang Chunyan
Chinese PLA General Hospital
Outcome results
None listed